Suit alleges that Medtronic tried to entice doctors to use its devices
Minneapolis Star Tribune, December 12, 2008
Documents filed in a federal whistleblower lawsuit against some of the nation's top spine surgeons hint at a lucrative financial relationship between Medtronic Inc. and several doctors at Twin Cities Spine Center, a Minneapolis practice. The whistleblower suit alleges that Medtronic offered consulting and royalty agreements to induce doctors to use its innovative bone-graft product, Infuse, in ways not approved by the U.S. Food and Drug Administration. Seven doctors at Twin Cities Spine are named in the suit.
- Interventional Radiology No Longer a Sub-Specialty
- NFP Hospitals' Revenue Growth at 'All-Time Low'
- Acute Kidney Injury Gets New Focus
- Transforming Cancer Care
- Half of All Primary Care, Internal Medicine Jobs Unfilled in 2013
- Evidence-Based Practice and Nursing Research: Avoiding Confusion
- mHealth Tackles Readmissions
- CNO Leads $1M Charge for New Scrubs, Uniforms
- Sharp HealthCare Leaves Pioneer ACO Program
- MA an Insurance Proving Ground for Providers